+91-8668442535

Enteral Tube Feeding Formula Market By Product (Standard Formulas, Disease-Specific Formulas) By Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, Others) By Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, Duodenal/Jejunal Tube Feeding) - Growth, Future Prospects & Competitive Analysis, 2016 - 2028

About this report

The global enteral tube feeding formula market report explores the critical analysis of the enteral tube feeding formula industry using key parameters. The report consists of investment strategies, the need for investments in the enteral tube feeding formula industry, and the multiple benefits for investors. Importantly, this report sets out major changes in the global technical regulations for the enteral tube feeding formulas industry and how economic and non-economic barriers are helping the market grow. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses include Porter's five forces analysis, PESTEL analysis, value chain analysis, etc.

REPORT ATTRIBUTE DETAILS

Enteral Tube Feeding Formula Market by Volume

Yes

Enteral Tube Feeding Formula Market by Value

Yes

Enteral Tube Feeding Formula Market, Tornado Analysis

Yes

Enteral Tube Feeding Formula Market, STAR Analysis

Yes

Enteral Tube Feeding Formula Market, SRC Analysis

Yes

Enteral Tube Feeding Formula Market, Import-Export Data

Yes (On Demand)

Enteral Tube Feeding Formula Market Pricing Analysis

Yes (On Demand)

Enteral Tube Feeding Formula Market Segment Analysis

By Product (Standard Formulas and Disease-Specific Formulas)

By Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others)

By Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal/Jejunal Tube Feeding)

By Stage (Adult and Pediatric)

By End Users (Hospitals and Long-Term Care Facilities)

Enteral Tube Feeding Formula Market, Regional Analysis

North America (the US and Canada)

Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, South East Asia, and the Rest of Asia Pacific)

Latin America (Brazil, Mexico, and the Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and the Rest of Middle East and Africa)

Enteral Tube Feeding Formula Market Key Companies

Medtrition Inc (US), Medline Industries Inc (US), Victus Inc (US), Hormel Foods Corporation (US), Global Health Products Inc (US), Mead Johnson & Company LLC (US), Nutritional Medicinals LLC (US), Nestle Health Science (Switzerland), Real Food Blends (US), B. Braun Melsungen AG (Germany), Fresenius Kabi Ltd (Germany), Abbott (US), and Meiji Holdings Co Ltd (Japan)

Enteral Tube Feeding Formula Market Competitive Landscape

Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted

 

Key Highlights of the report

How are the major segments performing in the Enteral Tube Feeding Formula Market?

  • The standard formulas segment led the market in products in 2021 and is expected to continue throughout the projection period owing to the standard formulae's widespread use and cost-effectiveness across all global patient groups. The easy availability of polymeric nutritional complete feeding formulae, suitable for use at home and in healthcare facilities, is another factor that is anticipated to facilitate the segment's long-term growth.
  • In 2021, the gastrostomy tube feeding segment held the largest global market share. The number of patients obtaining home enteral tube feeding is increasing globally owing to technological advancements, the development of percutaneous gastrostomy tube feeding procedures, and the shift in care delivery from acute to outpatient clinics. Gastrostomy tube feeding is a better option for people who need enteral nutrition for a prolonged period. For patients with gastrostomy tubes (G-tubes), standard formulas are highly preferred, and doctors frequently advise their patients to use them to improve their children's nutrition.
  • The oncology application segment dominated the global market in 2021 and is expected to continue during the forecast period. The prevalence of cancer is rising, more people are receiving care outside of hospitals, and more cancer patients are turning to enteral nutrition as a successful alternative to parenteral nutrition, all of which are expected to increase the market demand for enteral tube feeding formulas in oncological applications. Nutritional support for cancer patients has been proposed as a viable strategy for improving therapeutic outcomes.
  • The adult stage segment dominated the global market in 2021 due to the growing adoption of enteral tube feeding among adults suffering from various health conditions such as COPD, cancer, diabetes, stroke, multiple sclerosis, dementia, and chronic liver disease. Moreover, an increased preference for continuous feeding for hospitalized adult patients requiring enteral tube feeding nutrition therapy is expected to drive segment growth.
  • Long-term care facilities led the market in terms of end users in 2021, and this trend is expected to continue throughout the projection period. The provision of enteral nutrition to patients who require long-term, life-sustaining care beyond the hospital is expected to grow, accelerating the growth of long-term care facilities. Another significant factor influencing the segment's growth is that enteral tube feeding is frequently the only option for people suffering from chronic disorders and illnesses.

Which region dominated the enteral tube feeding formula market?

North America dominated the global enteral tube feeding formula market in 2021 and is expected to maintain its dominance throughout the forecast period due to the region's high prevalence of chronic diseases such as diabetes, cancer, and other neurological diseases. Moreover, increased awareness among people in the region about the advantages of tube nutrition in managing chronic medical conditions is expected to fuel the regional market. The adoption of tube nutrition in North America is also fueled by an increase in Americans suffering from gastrointestinal disorders. For instance, as per the Disease Prevention and Health Promotion report, chronic diseases account for 7 out of 10 fatalities annually in the United States.

How is US Market Performing in the enteral tube feeding formula market?

The market for enteral tube feeding formulas is rapidly growing, notably in the United States, owing to technological developments and widespread awareness of enteral tube feeding devices. Chronic diseases such as diabetes, cardiovascular disease, and kidney disease are common in the United States. This, combined with the country's growing elderly population, significantly impacts market development. As per the Population Bulletin Aging in the United States published by the Population Reference Bureau, the number of Americans 65 and older is expected to nearly double from 52 million in 2018 to 95 million by 2060. The prevalence of chronic diseases like cancer and diabetes will rise as the senior population grows, resulting in longer hospital stays for patients. As a result of high hospitalization rates, high inpatient care costs, and the nation's growing disease burden, the market is expected to grow in the United States.

What is the competitive environment of the enteral tube feeding formula market?

Market participants anticipate introducing new innovative products to broaden their portfolio and global reach. Market leaders with a broad product portfolio, huge global presence, and enhanced financial performance define the industry. For instance, Abbott widened its geographic reach in May 2022 by reactivating its manufacturing facility in Michigan. This step would help alleviate a nationwide baby formula shortage. Abbott is a market leader, with products sold and distributed in over 100 countries worldwide. Similarly, Danone announced the release of the first-ever Plants and Dairy Blend baby enteral tube feeding formula in July 2022 in response to parents' requests for flexitarian and vegetarian options for their infants.

Executive Summary

What are all the technical developments in the global enteral tube feeding formula market?

Enteral feeding is a technique for delivering nutrients into the digestive tract via a tube. Enteral feeding is used for patients who cannot swallow or digest enough food but have adequate intestinal functional capacity. Moreover, advancements in enteral tube feeding devices and product innovations are expected to drive the market during the projected period. Key players are focusing on diversifying their product portfolios by developing advanced medical feeding devices to deliver enteral nutrition and meet the needs of patients in home healthcare settings and intensive care units. For instance, Witleaf introduced the Brio-Enteral Nutrition Pump (EFP) in November 2021, an easy-to-use rotary peristaltic pump that enables enteral nutrition delivery. The device has light and sound alarm functionality to warn the user of a pipeline blockage or low battery voltage, making it safe and accurate.

Which are the key investments by the enteral tube feeding formula market players?

Major companies invest continuously in R&D activities to create new formulations that meet the needs of patients. These companies are also looking for strategic collaborations with other players through investments in partnerships and mergers to expand their product lines and utilize their technological capabilities. For instance, Fidmi Medical Ltd, a portfolio company of The Trendlines Group (Trendlines), announced in February 2022 that it had received a USD 2 million investment from B. Braun Melsungen AG (B. Braun). Fidmi Medical created a new, low-profile enteral tube feeding device that addresses the shortcomings of existing solutions. Likewise, Baxter International Inc and VIPUN Medical collaborated in July 2020 to commercialize the Gastric Monitoring System. This system includes a smart enteral feeding tube that measures stomach motility, allowing clinicians in the ICU (Intensive Care Unit) and other clinical settings to make better nutrient decisions.

Some major players in the enteral tube feeding formula market are Medtrition Inc (US), Medline Industries Inc (US), Victus Inc (US), Hormel Foods Corporation (US), Global Health Products Inc (US), Mead Johnson & Company LLC (US), Nutritional Medicinals LLC (US), Nestle Health Science (Switzerland), Real Food Blends (US), B. Braun Melsungen AG (Germany), Fresenius Kabi Ltd (Germany), Abbott (US), and Meiji Holdings Co Ltd (Japan).

enteral-tube-feeding-formula-market

What are the Major Driving Factors for the Enteral Tube Feeding Formula Market?

The rising prevalence of cancer, dementia, stroke, multiple sclerosis, chronic obstructive pulmonary disease (COPD), liver ailments, and other chronic diseases is driving the rapid growth of the enteral feeding formula market. Another significant factor boosting the market's growth is the increase in preterm births. The rising prevalence of cancer, the shift from healthcare facilities to outpatient care settings, and the growing adoption of enteral tube feeding formulas as an effective substitute for parenteral nutrition among many cancer patients are all most likely to increase the demand for enteral tube feeding formulas in the oncological applications over the forecast period.

What are the Major Risks for the Enteral Tube Feeding Formula Market?

The existence of allergic components in the product is anticipated to limit market expansion. Many different formulas are used to feed patients during enteral procedures, and using one on someone who is not a good candidate for it can have unfavorable side effects. A small proportion of patients receiving enteral nutrition support struggle with various issues, such as sinusitis, nasal erosions, cerebral or bronchial insertion, and mechanical, gastrointestinal, and metabolic problems. 20% of people with digestive issues vomit and feel sick when fed through a tube. Nausea, bloating, abdominal cramping, and vomiting are possible side effects for patients who receive excessive nutritional content doses. As a result, these issues limit enteral tube feeding use, restricting the market growth.

Which is the key product in the enteral tube feeding formula market?

The standard formulas product segment is projected to expand the fastest during the forecast period. Standard formulas are the most commonly used category for patients requiring enteral tube feedings. Standard formulas frequently have nutrient compositions that are designed to match recommendations for healthy people. Several common enteral feeding formulas are also used for oral supplements and tube feeding. Some contain extra nutrients, like fiber, which is good for bowel function and the digestive system. Standard formulas include monomeric formulas, polymeric recipes, and other modular diets. Polymeric formulae are suitable for use in hospitals and at home as they are nutritionally dense and primarily composed of nutrient content that is still intact, implying a fully operational digestive system. As a result, these formulations are regularly used after surgeries and for various ailments. Latest product advancements and the widespread use of these standard formulas are expected to drive market growth.

How is the enteral tube feeding formula market performing in regions?

North America dominated the enteral tube feeding formula market in 2021, owing to a rapidly aged population, an increase in preterm births, and an increase in patients with chronic conditions. According to the Centers for Disease Control and Prevention, preterm birth affected one in ten babies born in the United States in 2019. The prevalence of chronic diseases is increasing due to lifestyle modifications and hectic daily routines, and awareness of newborn malnutrition is the primary driver of growth in the region. According to the American Heart Association's 2021 report, coronary heart disease accounted for approximately 42.1% of all deaths in the United States that were directly attributable to cardiovascular disorders in 2019. Cardiovascular disorders were the leading cause of death in the country in 2019. As a result, the country's increasing use of enteral feeding formula would increase the demand for treatments that use it, creating a favorable environment for the growth of the North American enteral feeding formula market. Besides, the growth of the regional markets for enteral tube feeding formula is further aided by the increased focus on product development activities and the high interest of producers in accessing local markets. Therefore, the interaction of several factors, including a sizable patient population, supportive reimbursement policies, and new product introductions in the region, will boost the North American market during the forecast period.

Furthermore, the Asia Pacific region is expected to have the highest revenue share in the global enteral tube feeding formula market during the forecast period due to an increasing geriatric population, increased awareness of and availability to developed healthcare facilities, soaring healthcare spending, the increasing focus of major industry players on emerging regional countries, and rapid advancements in the medical insurance sector. Another important factor boosting regional growth is the rising rate of preterm births in Asian nations. The WHO estimates that Asia and sub-Saharan Africa account for 60% of all preterm birth cases. The top five nations with the highest rates of preterm births are Pakistan, Nigeria, China, India, and Indonesia. In addition, rising healthcare spending in many Asian nations, including India, China, Japan, and Singapore, as well as increased awareness of better nutrition management, are anticipated to propel the regional market over the forecast period. One of the primary factors influencing the enteral tube-feeding formula market is the rising incidence of cancer and other chronic conditions in India and China, where patients cannot or do not want to consume food orally and require tube feeding. The major market participants are investing in development due to the region's high prevalence of various disorders to seize business opportunities.

What is the regulatory landscape for the enteral tube feeding formula market?

The enteral feeding formula market is expected to expand rapidly due to enhanced government efforts, improved healthcare service penetration, and a rise in private and public institutions. The French government implemented the French National Nutrition and Health Program (PNNS) to improve public health and reduce disease risk. A rise in government campaigns to promote the use of enteral feeding tubes or pumps for enhancing health is some of the factors promoting segment expansion. Therapeutic nutrition is supported in several ways by international organizations, foundations, and governments. The primary funding agencies are the US Department of Agriculture, the National Institutes of Health, the Nestle Foundation, and the Robert Wood Johnson Foundation.

What is the Market Size of Enteral Tube Feeding Formula regarding value?

The global enteral tube feeding formula market is anticipated to grow at a substantial CAGR of 5.1% in the upcoming years. The global enteral tube feeding formula industry is estimated to be worth USD 6548.5 million in 2021 and is expected to be worth USD 8825.88 million by 2028.

What are the major players planning for the future of the enteral tube feeding formulas market?

The leading nutraceutical and pharmaceutical companies plan to invest heavily in research and development (R&D) activities, resulting in product innovations propelling global market growth. The rise in the implementation of strategic initiatives to increase their market foothold by key players such as Nestle, Abbott, and Fresenius Kabi further supports market expansion. Players in the enteral feeding formulas industry focus on customized feeding formulas to cater to specific indications. Tube feeding is used to keep nutrition and nitrate balance stable. This drives the market growth in the future. Abbott Laboratories is a leading player that provides liquid formulations that can be tube-fed to cancer patients to keep their nutrient levels stable.

Segmentation of Global Enteral Tube Feeding Formula Market -

Global Enteral Tube Feeding Formula Market – By Product

  • Standard Formulas
  • Disease-Specific Formulas

Global Enteral Tube Feeding Formula Market – By Application

  • Oncology
  • Neurology
  • Critical Care
  • Diabetes
  • Gastroenterology
  • Others

Global Enteral Tube Feeding Formula Market – By Type of Tube Feeding

  • Gastric Tube Feeding
  • Nasogastric Tube Feeding
  • Gastrostomy Tube Feeding
  • Duodenal/Jejunal Tube Feeding

Global Enteral Tube Feeding Formula Market – By Stage

  • Adult
  • Pediatric

Global Enteral Tube Feeding Formula Market – By End User

  • Hospitals
  • Long-Term Care Facilities

Global Enteral Tube Feeding Formula Market – By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Frequently asked questions about the global enteral tube feeding formula market

There is a rise in the use of enteral tube feeding formulas during the Covid-19 pandemic, along with the prevalence of several chronic illnesses and eating disorders. The adoption of enteral tube feeding is anticipated to rise over the forecast period as it plays a significant part in healing and rehabilitation.

North America accounted for the most heightened share in the global enteral tube feeding formulas market.

The increasing rate of preterm births, soaring healthcare costs, an aging population, and a growing preference for home care are the main factors propelling the global market for enteral tube feeding formulas.

The oncology segment had a major share in the global market in 2021.

The standard formulas segment had a major share in the global market.

Enteral Tube Feeding Formula Market Scope

Report Attribute Details
Market Value in 2021 USD 6548.5 million
Market Value in 2028 USD 8825.88 million
CAGR 5.1%
Benchmarking Year 2021
Past data 2016 – 2021
Forecast period 2022 – 2028
Choose License Type
Trusted By
Godaddy
Published Date:  Nov 2022
Category:  Medical Devices
Report ID:   60799
Report Format:   PDF
Pages:   130
Rating:    4.6 (50)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support